Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan-Reference-Cited by-同舟云学术

Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan

Published:2019-11 Issue:11 Volume:28 Page:104305
ISSN:1052-3057
Container-title:Journal of Stroke and Cerebrovascular Diseases
language:en
Short-container-title:Journal of Stroke and Cerebrovascular Diseases

Author:

Tanaka Koji^ORCID,Matsumoto Shoji,Yamada Takeshi,Nagano Sukehisa,Takase Kei-ichiro,Hatano Taketo,Yamasaki Ryo,Kira Jun-ichi

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Clinical Neurology,Rehabilitation,Surgery

Reference31 articles.

1. Impact of the approval of intravenous recombinant tissue plasminogen activator therapy on the processes of acute stroke management in Japan: the Stroke Unit Multicenter Observational (SUMO) Study;Sato;Stroke,2009

2. Stroke databank 2015;Kobayashi,2015

3. Dissemination of thrombolysis for acute ischemic stroke across a nation: experiences from the Swedish stroke register, 2003 to 2008;Eriksson;Stroke,2010

4. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years;Adeoye;Stroke,2011

5. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals;Schwamm;Circ Cardiovasc Qual Outcomes,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of working hours on prognosis of acute ischemic stroke patients following alteplase intravenous thrombolysis;Journal of International Medical Research;2024-08

2. Implementation of the Helsinki Model at West Tallinn Central Hospital;Medicina;2022-08-29

3. Neuroprotection in Acute Ischemic Stroke: A Battle Against the Biology of Nature;Frontiers in Neurology;2022-05-31

4. Differences between predictive factors for early neurological deterioration due to hemorrhagic and ischemic insults following intravenous recombinant tissue plasminogen activator;Journal of Thrombosis and Thrombolysis;2019-12-17

5. Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis;Journal of Thrombosis and Thrombolysis;2019-11-19